Back to search

University of Sheffield

Manipulation of RNA and RNA-Binding Proteins for Control of Biopharmaceutical Titre

Abstract

dc:description.abstract

The biopharmaceutical industry is at a crossroads, where changing industry and ethical demands means it must invest in research and development (R&D) to maintain a diverse pipeline of novel drugs, and simultaneously reduce the substantial risks and costs associated with this R&D. In the future, a complete toolkit of synthetic expression elements could be used to create a streamlined, rationalised next generation cell line development (CLD) process, maximising the benefits offered by synthetic biology. However, synthetic, predictable, titratable molecular biology tools have not yet been developed for all the desired steps of biopharmaceutical expression. In this thesis, I will present work endeavouring to expand this toolbox, by investigating synthetic control of glycoprotein expression through messenger RNA (mRNA) engineering. The tethering of various RNA-binding proteins to recombinant mRNA was tested, as a method of controlling mRNA processing, and stimulating intronless mRNA export. C1orf35 and HuR were identified as target effector genes to increase transient protein production. However, inconsistency in their effect disqualified them as effective molecular biology tools. Two families of 3’ untranslated region (UTR) RNA elements were screened for their ability to control productivity through enhancement of mRNA stability. Though triple helices failed to increase expression, a stability element was discovered to increase transient SEAP productivity by 1.28-fold, via a mechanism of extension of SEAP mRNA half-life from 0.68h to 4.04h, compared to an industry-standard vector. 5’ terminal oligo-pyrimidine (TOP) motifs were investigated for their ability to control productivity through translation initiation. Enhancement of transient titre was demonstrated with various recombinant proteins and culture conditions, chemical supplements screened for their ability to specifically affect 5’TOP activation, mechanism of titre control investigated, and 5’TOP motifs integrated with synthetic proximal and core promoters. Different 5’TOP motifs were shown to control titre of a biotherapeutic fusion protein in an industry transient production process, up to a 2.12-fold increase compared to an industry-standard vector. These synthetic elements were screened together for their modularity, demonstrating titratable control of SEAP titre, from a 0.82-fold decrease to a 5.23-fold increase compared to an industry-standard vector. Further steps were then recommended, to render these tools truly predictable, and contribute maximally towards a rationalised, next-generation CLD process.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Baker, James Alexander
Advisors dc:contributor.advisor
  • James, David
  • Wilson, Stuart
  • Gibson, Suzanne

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.815523

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Baker, James Alexander. Manipulation of RNA and RNA-Binding Proteins for Control of Biopharmaceutical Titre. doctoral thesis, University of Sheffield, 2019.